The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ADAPTIVE BIOTECHNOLOGIES COR | COM | 00650F109 | BBG001J2PFF5 | 20,334,212 | 3,030,434 | SH | SOLE | 3,030,434 | 0 | 0 | ||
AKOYA BIOSCIENCES INC | COM | 00974H104 | BBG00JX4LRV6 | 34,716,631 | 4,697,785 | SH | SOLE | 4,697,785 | 0 | 0 | ||
GUARDANT HEALTH INC | COM | 40131M109 | BBG006D97VY9 | 24,202,483 | 676,047 | SH | SOLE | 676,047 | 0 | 0 | ||
MAXCYTE INC | COM | 57777K106 | BBG00R1W85V4 | 8,652,150 | 1,885,000 | SH | SOLE | 1,885,000 | 0 | 0 | ||
NANOSTRING TECHNOLOGIES INC | COM | 63009R109 | BBG0019K7GX4 | 11,043,909 | 2,726,891 | SH | SOLE | 2,726,891 | 0 | 0 | ||
NATERA INC | COM | 632307104 | BBG001J1BQ86 | 42,890,676 | 881,436 | SH | SOLE | 881,436 | 0 | 0 | ||
SONENDO INC | COM | 835431107 | BBG002082QR8 | 6,315,107 | 4,643,461 | SH | SOLE | 4,643,461 | 0 | 0 |